Galactosemia (GAL) (McKusick 230400) caused by deficiency of galactose-1-phosphate uridyltransferase (GALT: EC 2.7.712) is associated with an impaired ability to metabolize galactose, derived from ...

approximately 3,300 patients in the United States with 80-100 new births per year and approximately 4,400 patients in the EU with 120 new births per year suffer from galactosemia, a rare genetic ...

Galactosemia is a rare genetic metabolic disease that leads to an inability to metabolize the simple sugar galactose. The company's shares plunged 75% in Friday afternoon trade. The stock has lost ...

Looking for reliable medications to treat 'Galactosemia'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Galactosemia (G) is due to either partial or complete deficiency of the enzyme galactose-1-phosphate uridyl transferase (Ts). In females with G, there is a high incidence of premature ovarian ...